Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Therapy for Infants With Sickle Cell Anemia
NCT02090296Phase 2Withdrawn
- Sponsor
- Children's National Research Institute
- Start
- Feb 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxyurea in sickle cell anemia (SCA), sponsored by Children's National Research Institute. Planned start Feb 2014; status: withdrawn.
02
Drugs
hydroxyurea
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT02090296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02090296.